2023’s best medtech innovations
Category: Best Medical Technology
Nominee: CVRx’s Barostim
It was the first FDA-approved device ” that uses the power of the brain and nervous system to target cardiovascular disease,” CVRx President and CEONadim Yaredsaid at the time.
Earlier this year,data from a clinical trialsupported Barostim’s use as a safe, effective and durable treatment for patients with heart failure with reduced ejection fraction.
Tell Us What You Think!
You must belogged into post a comment.